Literature DB >> 11115446

Lung cancer in women: sex-associated differences in survival of patients undergoing resection for lung cancer.

H Minami1, M Yoshimura, Y Miyamoto, H Matsuoka, N Tsubota.   

Abstract

STUDY
OBJECTIVES: The aim of this study was to analyze various characteristics and survival in female patients treated surgically for lung cancer.
DESIGN: Retrospective clinical study. PATIENTS: From 1,242 consecutive cases of primary non-small cell lung cancer treated with pulmonary resection between June 1984 and December 1998, 337 female patients (27.1%) were chosen.
RESULTS: Female patients had the following characteristics: a significantly younger age at onset (62.5 +/- 0.56 years vs 64.1 +/- 0.31 years for men), a higher frequency of adenocarcinoma (86.0% vs 48.3% for men), and smaller tumors (32.7 mm vs 38.3 mm in diameter for men). Peripheral tumors were significantly more common in women than men (71.8% vs 50.6%, respectively). Among 686 patients with a history of smoking, the women smoked significantly less often (12.8% vs 91.4% for men). Complete resection was achieved significantly less often in women (79.6% vs 85.2% for men); however, women having complete resection survived significantly longer than their male counterparts. Women with a postoperative negative carcinoembryonic antigen (CEA) had a significantly better prognosis than men; however, women with a postoperative positive CEA did not. Women > or = 60 years old survived significantly longer than their male counterparts, while women < 60 years old did not.
CONCLUSIONS: Once the tumor was resected completely, women survived longer, partly due to the influence of life expectancy. However, the incidence of malignant effusion was higher and the rate of complete resection was lower in women.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11115446     DOI: 10.1378/chest.118.6.1603

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  17 in total

1.  Effect of gender on perioperative outcomes after robotic-assisted pulmonary lobectomy.

Authors:  Jessica R Glover; Frank O Velez-Cubian; Wei Wei Zhang; Kavian Toosi; Tawee Tanvetyanon; Emily P Ng; Carla C Moodie; Joseph R Garrett; Jacques P Fontaine; Eric M Toloza
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

Review 2.  Sex-specific aspects of tumor therapy.

Authors:  Kerstin Borgmann; Ekkehard Dikomey; Cordula Petersen; Petra Feyer; Ulrike Hoeller
Journal:  Radiat Environ Biophys       Date:  2009-02-26       Impact factor: 1.925

3.  Do tumor cavitation and sex in resected stage I non-small-cell lung cancer correlate with prognosis?

Authors:  Meng Wang; Jing Zhao; Yi Pan; Yan-Jun Su; Jian You; Xiao-Liang Zhao; Chang-Li Wang
Journal:  World J Surg       Date:  2009-03       Impact factor: 3.352

4.  Estrogen receptor alpha increases basal and cigarette smoke extract-induced expression of CYP1A1 and CYP1B1, but not GSTP1, in normal human bronchial epithelial cells.

Authors:  W Han; B T Pentecost; R L Pietropaolo; M J Fasco; S D Spivack
Journal:  Mol Carcinog       Date:  2005-11       Impact factor: 4.784

Review 5.  Population-based trends in lung cancer incidence in women.

Authors:  Brian L Egleston; Sibele I Meireles; Douglas B Flieder; Margie L Clapper
Journal:  Semin Oncol       Date:  2009-12       Impact factor: 4.929

6.  Long-term survival outcomes of video-assisted thoracic surgery for patients with non-small cell lung cancer.

Authors:  Wenlong Shao; Xinguo Xiong; Hanzhang Chen; Jun Liu; Weiqiang Yin; Shuben Li; Xin Xu; Xin Zhang; Jianxing He
Journal:  Chin J Cancer Res       Date:  2014-08       Impact factor: 5.087

7.  Phase II trial of gefitinib in pretreated Chinese women with advanced non-small-cell lung cancer.

Authors:  Jing Deng; Wei Jia Fang; Xiao Chen Zhang; Dong Ping Wu; Hong Ming Fang; Jing Chen; Jiong Qian; Hai Bo Mou; Bin Bin Chu; Nong Xu; Li Song Teng
Journal:  Med Oncol       Date:  2011-03-12       Impact factor: 3.064

8.  Risk factors for local and regional recurrence in patients with resected N0-N1 non-small-cell lung cancer, with implications for patient selection for adjuvant radiation therapy.

Authors:  J L Lopez Guerra; D R Gomez; S H Lin; L B Levy; Y Zhuang; R Komaki; J Jaen; A A Vaporciyan; S G Swisher; J D Cox; Z Liao; D C Rice
Journal:  Ann Oncol       Date:  2012-09-20       Impact factor: 32.976

Review 9.  Lung cancer in women: an overview with special focus on Spanish women.

Authors:  J Remon; E Molina-Montes; M Majem; P Lianes; D Isla; P Garrido; E Felip; N Viñolas; J de Castro; A Artal; M-J Sánchez
Journal:  Clin Transl Oncol       Date:  2013-11-26       Impact factor: 3.405

10.  Important prognostic factors for the long-term survival of lung cancer subjects in Taiwan.

Authors:  Tai-An Chiang; Ping-Ho Chen; Pei-Fen Wu; Tsu-Nai Wang; Po-Ya Chang; Albert Min-Shan Ko; Ming-Shyan Huang; Ying-Chin Ko
Journal:  BMC Cancer       Date:  2008-11-07       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.